Group A Streptococcus (GAS) causes diverse human infections ranging from mild pharyngitis to severe disease, including toxic shock syndrome, necrotizing fasciitis, and rheumatic fever (6, 33). The pathogen is characterized by extensive allelic variation and production of many virulence factors (23, 31, 38). The incidence of GAS disease has increased since the 1980s, renewing interest in the mechanisms of pathogenesis and the development of new therapeutic agents (33). Protection against GAS infection is mediated primarily by antibodies to extracellular proteins that are secreted and freely diffusible or anchored to the bacterial cell wall (6). However, the identification of relatively few antigens that contribute to a protective immune response, coupled with genetic and serologic diversity, has limited understanding of GAS-host interactions and impeded development and licensure of a human vaccine. Comparative genomics, proteomics, DNA microarray analysis, and other postgenomic strategies have provided many new avenues for investigating differences in pathogen phenotype, host specificity, and virulence determinants. Genes encoding proteins likely to be extracellular or displayed on the bacterial cell surface can now be identified by analysis of the genome sequence of the pathogen, facilitating rapid discovery of proteins that may interact with the host during natural infection (14, 21, 32). Analysis of genome sequence data can also assist identification of proteins that may confer protective immunity against infection. For example, Pizza et al. (35) analyzed the genome sequence of a serogroup B Neisseria meningitidis strain and identified 570 open reading frames (ORFs) that were predicted to encode novel exported or surface-exposed proteins. The ORFs were cloned, and recombinant proteins were purified and used for immunologic studies. Seven proteins generated an antibody response that conferred complement-mediated bactericidal activity in a murine model of infection. Molecular population genetic analysis indicated that five of the seven proteins were conserved among 31 N. meningitidis strains representative of the species diversity found in natural populations. Taken together, the results have stimulated additional research into the utility of using these proteins as a meningococcal vaccine. Analysis of the genomes of four GAS strains (serotypes M1, M3, M5, and M18) recently led to the discovery of four genes (spy0747, spy0843, spy0872, and spy1972) that encode novel extracellular proteins (Table (Table1)1) (37). The four proteins have conventional amino-terminal secretion signal sequences and have a carboxy-terminal LPXTG amino acid motif that covalently links many gram-positive bacterial virulence factors to the bacterial cell surface (13, 34, 37, 39). Sequencing and population genetic analysis of these four GAS genes in 37 strains revealed restricted allelic variation, indicating that the proteins are very well conserved in the species (37). Western immunoblot analysis conducted with acute- and convalescent-phase serum samples obtained from four patients with invasive infections indicated that all four of the recombinant proteins were reactive with one or more of the serum samples, consistent with the hypothesis that these proteins are produced during GAS infections (37). Taken together, these preliminary observations suggest that further analysis of these proteins is warranted. TABLE 1. Chromosomal location and putative function of four GAS genes The present study was undertaken to determine if these four proteins are expressed in multiple GAS disease types and to assess if variation exists in gene transcript level in different M types. Evidence was sought for in vivo expression of these proteins in infected humans by Western immunoblot analysis of sera obtained from 80 patients with invasive infections, noninvasive soft tissue infections, pharyngitis, and rheumatic fever. Inasmuch as there is considerable genetic variation among GAS strains, we analyzed the transcript level of the four genes at six time points throughout the growth cycle in three representative strains expressing serotype M1, M3, and M18 proteins. These strains were chosen for analysis because serotype M1 and M3 organisms commonly cause invasive infections worldwide, and M18 organisms have been implicated in pharyngitis and acute rheumatic fever (ARF) outbreaks in the United States (6, 33).